Search

everythinglearnresearchcommunity

for

Search:↓

Early and aggressive treatment with individualized care plans is crucial for managing pediatric systemic lupus erythematosus.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Pregnancy can cause symptoms similar to rheumatic diseases, making diagnosis difficult, and affects various body systems, requiring careful distinction between normal changes and serious conditions.

COVID-19 may trigger systemic lupus erythematosus in some people.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Alopecia areata mainly affects men aged 21-40 and is linked to autoimmune issues, thyroid problems, and inflammation.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Shea butter is profitable and essential for rural women, providing economic and medicinal benefits.

CBD might help pets with pain, itching, and seizures, but results are mixed and more research is needed.

Higher disease activity in systemic lupus erythematosus is strongly linked to more internal organ damage.

Older men with late-onset lupus have a higher mortality rate than women.

Testing for various autoantibodies in Indian children with lupus can help predict disease symptoms and risks.

Early treatment of mixed connective tissue disease is crucial to prevent severe autoimmune conditions.

Neuropsychiatric lupus is a severe form of lupus that needs strong treatment to improve life quality.

Rash in SLE patients indicates more severe disease.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Etanercept may not prevent alopecia areata from coming back.

Generalized vitiligo in Chinese patients is linked to other autoimmune diseases, especially in familial cases.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

Citrullinated proteins from Porphyromonas gingivalis may contribute to rheumatoid arthritis.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

Korean patients with rosacea are more likely to have other health conditions.

A patient's grey hair regained color during treatment with adalimumab.

Autoimmune and metabolic issues are linked, and treating one may worsen another.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.